Christelle Huguet, Ph.D.: key facts
- Kind of voice
- Sector leader
- Role
- R&D head and Executive Vice President at Ipsen
- Quoted on
- Rare diseases
- Press citations held
- 1
- Most recently quoted
- 30 Sept 2026
“These results are disappointing for the [FOP] community and patients living with this devastating disease. However, we do believe that these data will contribute to the growing body of research on FOP, giving new insights into managing this disease for patients and their care providers.”
Where Christelle Huguet, Ph.D. has been quoted
- Ipsen's hopes for next-gen rare disease drug dashed by pivotal phase 2 failfiercebiotech.com · 30 Sept 2026
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 30 Sept 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.